grand america hotel, salt lake city, utah wednesday, 12 ...€¦ · note: for green arrows, savings...
Post on 22-Sep-2020
3 Views
Preview:
TRANSCRIPT
##HASUMMIT18
Why Clinical QualityShould Be Your Core Business Strategy
Health CatalystHealthcare Analytics Summit 2018
Grand America Hotel, Salt Lake City, UtahWednesday, 12 September 2018, 9:00a – 9:45a
Brent C. James, M.D., M.Stat.Quality Science
##HASUMMIT18
SQ cienceuality
Disclosures
I receive a monthly retainer as a part time(3 days / month) senior advisor for Health Catalyst.
Other than that, neither I nor any family members have any relevant financial
relationships to be directly or indirectly discussed, referred to or illustrated within the
presentation, with or without recognition.
##HASUMMIT18
SQ cienceuality
A value proposition
The basis for variation research:
Investigators began to apply rigorousclinical research measurement methods
to
routine care delivery performance(that is, to quality of care)
##HASUMMIT18
SQ cienceuality
Quality, Utilization, and Efficiency (QUE)wSix clinical areas studied over 2 years:- transurethral prostatectomy (TURP)- open cholecystectomy- total hip arthroplasty- coronary artery bypass graft surgery (CABG)- permanent pacemaker implantation- community-acquired pneumoniawpulled all patients treated over a defined time period
across all Intermountain inpatient facilities - typically 1 year
widentified and staged (relative to changes in expected utilization)- severity of presenting primary condition- all comorbidities on admission- every complication- measures of long term outcomeswcompared physicians with meaningful # of cases
(low volume physicians included in parallel analysis, as a group)
James, B.C. What is a TURP? controlling variation in the performance of clinical processes.Improving Clinical Practice: Total Quality Management & the Physician (ed: D.B. Blumenthaland A.C. Scheck). San Francisco, CA: Jossey-Bass Publishers, 1995 (Chapter 7).
##HASUMMIT18
SQ cienceuality
Intermountain TURP QUE StudyMedian Surgery Minutes vs Median Grams Tissue
M L K J P B C O N A I D H E G F0
20
40
60
80
100
0
20
40
60
80
100
Attending PhysicianMedian surgical time Median grams tissue removed
Gra
ms
tissu
e / S
urge
ry m
inut
es
James, B.C. What is a TURP? controlling variation in the performance of clinical processes.Improving Clinical Practice: Total Quality Management & the Physician (ed: D.B. Blumenthaland A.C. Scheck). San Francisco, CA: Jossey-Bass Publishers, 1995 (Chapter 7).
##HASUMMIT18
SQ cienceuality
Intermountain TURP QUE Study
James, B.C. What is a TURP? controlling variation in the performance of clinical processes.Improving Clinical Practice: Total Quality Management & the Physician (ed: D.B. Blumenthaland A.C. Scheck). San Francisco, CA: Jossey-Bass Publishers, 1995 (Chapter 7).
##HASUMMIT18
SQ cienceuality
The opportunity (care falls short of its theoretic potential)
1. Massive variation in clinical practices (beyond even the remote possibility that all patients receive good care)
2. High rates of inappropriate care (where the risk of harm inherent in the treatment outweighs any potential benefit)
3. Unacceptable rates of preventable care-associated patient injury and death
4. Striking inability to "do what we know works"
5. Huge amounts of waste, leading to spiraling prices that limit access to care
James, B.C. Testimony to the U.S. Senate Finance Committee, February 2009
##HASUMMIT18
SQ cienceuality
The waste opportunity is HUGE
30-50+% of all health care resource expenditures are
quality-associated waste:• recovering from preventable foul-ups• building unusable products• providing unnecessary treatments• simple inefficiency
Institute of Medicine Roundtable on Value and Science-Driven Healthcare. The Healthcare Imperative:Lowering Costs and Improving Outcomes. Yong, Pierre L., Saunders, Robert S., and Olsen, LeighAnne, editors. Washington, DC: National Academy Press, 2010.
##HASUMMIT18
SQ cienceuality
MUCH higher financial leverage from waste elimination than revenue growth
NetOperating
Margin(and return on investment)
Revenue growth:5 to 9% contribution
for each case added
Waste elimination:50 to >100% contribution
for each case avoided
##HASUMMIT18
SQ cienceuality
Case-rate utilization(# cases per population)
Within-case utilization(# and type of units per case)
Efficiency(cost per unit of care)
1.
2.
3.
% of allwaste
45%
50%
5%
Examples of removing waste
Waste class
a) Inappropriate cases (risk outweighs benefit)(e.g., many cath lab procedures; CTPA)
b) Preference-sensitive cases(when given a fair choice, many patients opt out)(e.g., elective hips, knees; end-of-life care)
c) Avoidable cases(hot spotting; move upstream)(e.g., team-based care)
Waste subclasses
a) Supply chain
a) Clinical variation(e.g., QUE studies; surgical equipment)
b) Avoidable patient injuries(e.g., serious safety event systems; CLABSI)
c) Administrative inefficiencies- regulatory burden - billing thrash- TPS Lean observation - current EMR function
##HASUMMIT18
SQ cienceuality
Financial incentive alignment under
different payment mechanisms
Note: For green arrows, savings from waste elimination accrue to the care
delivery organization; for red arrows, savings go to payer organizations.
Case-rate utilization(# cases per population)
Within-case utilization
(# and type of units per case)
Efficiency(cost per unit of care)
FFS
Per
case
Provider
at risk
WASTE REMOVALLEVEL
PAYMENT METHOD
1.
2.
3.
% of allwaste
45%
50%
5%
James Brent C and Poulsen Gregory P. The case for capitation: It’s the only way to cut wastewhile improving quality. Harv Bus Rev 2016; 94(7-8):102-11, 134 (Jul-Aug).
##HASUMMIT18
SQ cienceuality
To be “business viable,” waste elimination requires financial alignment
Ø Waste elimination always requires investmentØ The group that makes the investment
must harvest sufficient waste savings to insurefinancial survival (plus, hopefully, a contribution to operating margins)
Ø Key questions:- Who makes the investment?- Who gets the savings?
##HASUMMIT18
SQ cienceuality
-11%-22% -21%
+4%+13%
-11%
1
Emergency Room Visits
Hospital Admits
PCP Visits
Urgent Care Visits
Radiology Tests
Other Avoidable Visits and
Admissions
Team-Based Care(3rd generation coordinated medical home)
An investment of $22 per-member-per year (PMPY) decreased medical
expenses by $115 PMPY
Reiss-Brennan B, Brunisholz KD, Dredge C, Briot P, Grazier K, Wilcox A, Savitz L, and James B. Association of integrated team-based care with health care quality, utilization, and cost. JAMA 2016; 316(8):826-34 (Aug 23/30).
##HASUMMIT18
SQ cienceuality
0
2
4
6
8
10
12
14
1988 1989 1990
0
2
4
6
8
10
12
141 2 3 4 5 6 7 8 9 10 11 12 1 2 3 4 5 6 7 8 9 10 11 12 1 2 3
1988 1989 1990
Month/Year
Aver
age
cost
per
cas
e ($
1,00
0s)
1 2 3 4 5 6 7 8 9 10 11 12 1 2 3 4 5 6 7 8 9 10 11 12 1 2 3
Total Hip Arthroplasty - Cost
James, B.C. Quality Management for Health Care Delivery (monograph). Chicago, IL:Hospital Research and Educational Trust (American Hospital Association), 1989.
##HASUMMIT18
SQ cienceuality
Financial impact of clinical qualityimprovement at Intermountain
$3,000
$3,500
$4,000
$4,500
$5,000
$5,500
$6,000
2011 2012 2013 2014 2015 2016
Net
Rev
enue
(in M
illio
ns)
Status Quo Net Rev 2011 5-Yr Plan Net Rev
$728MM(~13%)
$688MM(~13%)
James Brent C and Poulsen Gregory P. The case for capitation: It’s the only way to cut wastewhile improving quality. Harv Bus Rev 2016; 94(7-8):102-11, 134 (Jul-Aug).
##HASUMMIT18
SQ cienceuality
Within the healing professions,
We count our successes in lives
Lesson 1
##HASUMMIT18
SQ cienceuality
Nearly always with proper clinical management
better care is cheaper carethrough waste elimination
The path to financial success leads through clinical management
Lesson 2
##HASUMMIT18
SQ cienceuality
None of our successes came fromcomparing ourselves to others
Ø In every instance, we were already at or near top of class when we startedØ Instead, we tracked the gap arising from “best possible” careØ This principle is especially true with regard to nationally-mandated reporting
It came through solid analyticsbased on good internal data
Lesson 3
##HASUMMIT18
SQ cienceuality
Lesson 4
The long-term organizational viability ofclinical quality improvement strategies
requires aligned financial incentives
##HASUMMIT18
SQ cienceuality
What does the future hold?
Walter Gretzky (Wayne Gretzky’s father):Skate to where the puck is going to be, not where it has been.
##HASUMMIT18
SQ cienceuality
“Pay for value” continues to growForward looking indicators:
ØKaiser Permanente (continued rapid growth within existing geographic markets, mostly)
ØMedicare Advantage (continued rapid growth)
ØACOs (Leavitt Group; mostly commercial)
ØERISA direct to provider contracting(11% of large employers, according to Modern Healthcare)
ØProvider-payer consolidationby ownership or partnership (e.g., United Healthcare)
##HASUMMIT18
SQ cienceuality
Implications – we will see:Ø Increasing focus on waste elimination through
“move upstream” strategies: primary care-based population health; clinical variation control using clinical decision support tools (a.k.a. clinical knowledge management = “learning healthcare systems”)
Ø Care delivery organizations will increasingly seek capitated risk through ownership or partnership (a.k.a. “pay for value); watch for payer/care provider consolidation
Ø Stand-alone specialty care practices and hospitals will increasingly become “price takers” – intense competition mainly around payment rates
##HASUMMIT18
SQ cienceuality
Health IT will matureØ EMR’s primary purpose will shift to clinical decision
support – away from their current focus on maximizing fee for service billing
Ø The resulting systems will be much more clinically natural and adaptable – massively improving productivity and eliminating the primary source of burnout in clinical practice today
Ø Analytics, including AI and machine learning, will explode – quality reporting will be a direct extension of internal operational data, just as happens today in financial systems (i.e., SEC, GAAP, GAAS, annual independent financial audits)
##HASUMMIT18
SQ cienceuality
The past:1. "Top-line" revenue enhancement
- Systems designed around documentation to support FFS payment, clinical decision support as a secondary "bolt-on"
2. Quality defined as regulatory compliance- e.g. CMS Core Measures, Pay for Value, Meaningful Use
The future:1. Quality becomes the core business
- Demonstrated performance for key clinical processes- Systems designed around clinical decision support (process management),
producing documentation as an integrated by-product 2. "Bottom-line" cost control and waste elimination
in a "provider at risk" financial environment
A fundamental shift in focus (disruption?)
Used with permission from Intermountain Healthcare. ©1998 Intermountain Healthcare. All rights reserved.
##HASUMMIT18
SQ cienceuality
Better has no limit ...an old Yiddish proverb
top related